ME1
Melodiol Global Health Limited
📦 LOGISTICS
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-19.88%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
35
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Melodiol Global Health Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. Its cannabidiol (CBD) plant-based nutraceutical products are non-psychoactive, as they only contain trace amounts of tetrahydrocannabinol (THC). Its product is offered under various brands, including Green Goo, Southern Butter, Good Goo, Ritual, impactive and cannaQIX, among others. The company cultivates and harvests cannabis plants through its subsidiary, Mernova Medicinal Inc. and supplies cannabis retail products throughout Canada. Through its wholly owned, Canada-based psychedelics subsidiary, Halucenex Life Sciences Inc., it is also focused on the development of synthetic and botanical psilocybin treatments for treatment-resistant post-traumatic stress disorder, and other mental health conditions.
📈 Performance
Price History
-98.50%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price
$0.00
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ME1
35
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ME1
186 days
ME1 investor breakdown
💵 Income of investors
More than 200k
150k - 200k
7%
100k - 150k
33%
50k - 100k
40%
Less than 50k
17%
👶 Age of investors
18 - 25
26 - 34
40%
35 - 90
54%
🙋 Cis-gender of investors
Female
26%
Male
74%
Pearlers who invest in ME1 also invest in...
🙌 Performance (5Yr p.a)
-19.23%
📊 Share price
$0.02 AUD
Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. Its cannabidiol (CBD) plant-based nutraceutical products are non-psychoactive, as they only contain trace amounts of tetrahydrocannabinol (THC). Its product is offered under various brands, including Green Goo, Southern Butter, Good Goo, Ritual, impactive and cannaQIX, among others. The firm cultivates and harvests cannabis plants through its subsidiary, Mernova Medicinal Inc. (Mernova) and supplies cannabis retail products throughout Canada. Through its wholly owned, Canada-based psychedelics subsidiary, Halucenex Life Sciences Inc. (Halucenex), it is also focused on the development of synthetic and botanical psilocybin treatments for treatment-resistant post-traumatic stress disorder, and other mental health conditions.
📊 Share price
$0.01 AUD
Want more shares? Try these...
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The Company’s segments include Australia, the United States, the United Kingdom and Asia Operations. The Company’s products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Company’s subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
🙌 Performance (5Yr p.a)
99.64%
📊 Share price
$0.34 AUD
🩺 HEALTH CARE
Mindax Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-12-08. The Company’s portfolio of projects includes iron ore and gold. Its projects include the Mt Forrest Iron Project, Mt Lucky Gold project and Meekatharra North Project. The Mt Forrest iron project is in the Yilgarn province. The company comprises seven mining leases and is located 600 kilometers (km) from the Port of Geraldton and 165 km from the southbound railway at Menzies and around 648 km from the port at Esperance. The project is a world-scale iron ore resource. The Meekatharra North Project comprises one granted exploration license, E51/1705. The Meekatharra North Project is a gold-mining center in the Murchison Goldfields of Western Australia. The project is located 40 km north of the township of Meekatharra, at the northern end of the Meekatharra Greenstone Belt, in the Murchison Province, Western Australia. Mt Lucky lies within the Mt Margaret Mineral Field of the north-eastern Goldfields of Western Australia.
🙌 Performance (5Yr p.a)
100.00%
📊 Share price
$0.03 AUD
⛏️ MINING